IGFBP7 and brain neoplasm: The results of the study suggest that anti-IGFBP7 sdAbs and anti-IGFBP7 sdAb-PEGylated-NPs are both promising molecular imaging agents for targeting brain tumour vessels with potential for clinical translation.